Tempus AI, Inc. (NASDAQ:TEM) EVP Andrew Polovin Sells 51,504 Shares

Tempus AI, Inc. (NASDAQ:TEM) EVP Andrew Polovin sold 51,504 shares of Tempus AI stock in a transaction on Wednesday, December 11th. The stock was sold at an average price of $42.39, for a total transaction of $2,183,254.56. Following the transaction, the executive vice president now directly owns 246,085 shares of the company’s stock, valued at approximately $10,431,543.15. This trade represents a 17.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Tempus AI Trading Down 2.4 %

Shares of Tempus AI stock opened at $41.00 on Friday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $79.49. The business’s 50-day moving average price is $52.64.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on TEM. Bank of America raised their target price on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday. Guggenheim began coverage on Tempus AI in a report on Monday, December 9th. They set a “buy” rating and a $74.00 price objective for the company. Stifel Nicolaus downgraded Tempus AI from a “buy” rating to a “hold” rating and upped their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Wolfe Research started coverage on Tempus AI in a research note on Friday. They issued an “outperform” rating and a $60.00 price target for the company. Finally, Piper Sandler reiterated a “neutral” rating and set a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $56.00.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. bought a new position in Tempus AI in the third quarter valued at about $30,000. Sandia Investment Management LP acquired a new stake in shares of Tempus AI in the 2nd quarter valued at approximately $136,000. Vestor Capital LLC acquired a new stake in shares of Tempus AI in the 3rd quarter valued at approximately $153,000. Stifel Financial Corp bought a new stake in shares of Tempus AI during the 3rd quarter valued at approximately $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new position in Tempus AI during the 3rd quarter worth approximately $258,000. 24.22% of the stock is owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.